Search Results

Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Fetal (CWD - N)
Peripheral Vascular (CWD - N)

The system consists of a main body and one probe. The nominal 2 or 3 MHz probes are designed for fetal applications. The nominal 5 or 8MHz probes are designed for peripheral vascular applications.

The provided text is related to an FDA 510(k) premarket notification for the "DigiDop Ultrasound System." This document discusses the substantial equivalence of the device to legally marketed predicate devices and outlines its intended uses and transducer types. It is not an AI/ML device and therefore does not include:

• Acceptance criteria and reported device performance related to AI/ML.
• Sample sizes, data provenance, number of experts for ground truth, or adjudication methods for test sets.
• Multi-reader multi-case comparative effectiveness studies or standalone algorithm performance.
• Ground truth types or sample sizes/ground truth established for training sets.

The document is purely a regulatory approval for a medical device that uses ultrasound technology to detect fetal heartbeats and for peripheral vascular diagnosis. It does not involve any artificial intelligence or machine learning components.

Ask a specific question about this device

Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Fetal (Mode of Operation: CWD)

Not Found

This document is a 510(k) clearance letter for the BabyBeat Cordless fetal ultrasonic monitor and accessories, issued by the FDA in 2006. It does not contain information about acceptance criteria or a study proving the device meets acceptance criteria.

The letter acknowledges that the device is substantially equivalent to legally marketed predicate devices and therefore can be marketed, subject to general controls provisions of the Act and additional controls for Class II devices.

The only specific requirement mentioned that relates to performance is a postclearance special report that must contain "complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." The letter states that if this report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply.

However, this is a post-market requirement for production units, not a pre-market study designed to define or meet specific acceptance criteria for performance metrics. The document does not provide:

1. A table of acceptance criteria and reported device performance.
2. Sample sizes used for test sets or data provenance.
3. Number or qualifications of experts for ground truth.
4. Adjudication method for test set.
5. MRMC comparative effectiveness study.
6. Standalone performance study results.
7. Type of ground truth used.
8. Sample size for the training set.
9. How ground truth for the training set was established.

Ask a specific question about this device